Index of /collected-databases/Asinex

[ICO]NameLast modifiedSizeDescription

[PARENTDIR]Parent Directory   -  
[   ]2019-04-RNA-targetin..>2025-07-05 13:13 29K 
[   ]2020-07-Asinex-Build..>2025-07-05 13:13 22K 
[   ]2020-07-Asinex-CNS-1..>2025-07-05 13:13 1.8M 
[   ]2020-07-Asinex-Epige..>2025-07-05 13:13 84K 
[   ]2020-07-Asinex-GPCR-..>2025-07-05 13:13 133K 
[   ]2020-07-Asinex-Immun..>2025-07-05 13:13 99K 
[   ]2020-07-Asinex-Kinas..>2025-07-05 13:13 95K 
[   ]2020-07-Asinex-Lipid..>2025-07-05 13:13 37K 
[   ]2020-10-Asinex-Dinuc..>2025-07-05 13:13 13K 
[   ]2020-10-Asinex-Fragm..>2025-07-05 13:13 17K 
[   ]2020-10-Asinex-Macro..>2025-07-05 13:13 28K 
[   ]2020-11-Asinex-in-GO..>2025-07-05 13:13 652K 
[   ]2020-11-SND-Covalent..>2025-07-05 13:13 188K 
[   ]2021-02-Asinex-BB-22..>2025-07-05 13:13 352K 
[   ]2021-02-AsinexFragme..>2025-07-05 13:13 313K 
[   ]2021-04-Asinex-Coval..>2025-07-05 13:13 126K 
[   ]2021-04-Asinex-Macro..>2025-07-05 13:13 158K 
[   ]2021-04-Asinex-Metal..>2025-07-05 13:13 28K 
[   ]2021-09-PrePlate-Mac..>2025-07-05 13:13 0  
[   ]2022-04-CRBN-binding..>2025-07-05 13:13 1.1K 
[   ]2022-04-asinex-dinuc..>2025-07-05 13:13 11K 
[   ]2022-04-molecular-gl..>2025-07-05 13:13 20K 
[   ]2022-08-asinex-coval..>2025-07-05 13:13 12K 
[   ]2023-05-molecular-gl..>2025-07-05 13:13 21K 
[   ]AntiViral_6827_06072..>2025-07-05 13:13 107K 
[   ]Asinex-Antibacterial..>2025-07-05 13:14 93K 
[   ]Asinex-Nucleoside-Mi..>2025-07-05 13:14 49K 
[   ]Asinex-PPI-Macro_311..>2025-07-05 13:14 49K 
[   ]Asinex-Peptidomimeti..>2025-07-05 13:14 143K 
[   ]Asinex-Steroid-Mimet..>2025-07-05 13:14 23K 
[   ]Asinex-Terpenoids_42..>2025-07-05 13:14 67K 
[   ]AsinexCNSMacrocycles..>2025-07-05 13:14 18K 
[   ]AsinexSignatureLibra..>2025-07-05 13:14 0  
[   ]Asinex_Pre-Plated-Fo..>2025-07-05 13:14 15K 
[   ]IonChannel_8559_0607..>2025-07-05 13:14 134K 
[   ]Kinase-type-II-inhib..>2025-07-05 13:14 37K 
[   ]PPI_11439_060720.sdf..>2025-07-05 13:14 179K 
[   ]Peptidergic-GPCR-Mac..>2025-07-05 13:14 98K 
[   ]Pre-Plated_CNS_Diver..>2025-07-05 13:14 0  
[   ]PrePlated-Glycomimet..>2025-07-05 13:14 0  
[   ]PrePlated-Kinase_649..>2025-07-05 13:14 0  
[   ]PrePlated-PPI_3743_2..>2025-07-05 13:14 0  
[   ]PrePlated-Phenotypic..>2025-07-05 13:14 0  
[   ]Signal-Pathway-Inhib..>2025-07-05 13:14 75K 
[   ]Targeted-Oncology_48..>2025-07-05 13:15 75K 
[   ]asinex-a-helix-mimet..>2025-07-05 13:13 107K 
[   ]asinex-all-screening..>2025-07-05 13:14 8.8M 
[   ]asinex-all-screening..>2025-07-05 13:14 0  
[   ]asinex-bio-design-17..>2025-07-05 13:14 2.6M 
[   ]asinex-elite-synergy..>2025-07-05 13:14 1.4M 
[   ]asinex-glycomimetics..>2025-07-05 13:14 67K 
[   ]asinex-gold-platinum..>2025-07-05 13:14 4.0M 
[   ]asinex-macrocyclic-g..>2025-07-05 13:14 22K 
[   ]diversity-pre-plated..>2025-07-05 13:14 0  
[   ]nucleoside-mimetics-..>2025-07-05 13:14 60K 
[   ]nucleoside-pre-plate..>2025-07-05 13:14 0  
[   ]sl-01-mcl-1.sdf.list 2025-07-05 13:14 1.3K 
[   ]sl-02-bcl-xl.sdf.list 2025-07-05 13:14 1.3K 
[   ]sl-03-wnt-inhibitors..>2025-07-05 13:14 1.3K 
[   ]sl-04-oncology-pheno..>2025-07-05 13:14 1.3K 
[   ]sl-05-51-ion-channel..>2025-07-05 13:14 1.3K 
[   ]sl-06-07-17-28-glyco..>2025-07-05 13:14 1.3K 
[   ]sl-08-16-36-39-100-m..>2025-07-05 13:14 1.3K 
[   ]sl-09-pampa-macrocyc..>2025-07-05 13:14 1.3K 
[   ]sl-10-52-98-purine-b..>2025-07-05 13:14 1.3K 
[   ]sl-11-mdm2-p53.sdf.list2025-07-05 13:14 1.3K 
[   ]sl-12-wnt-activators..>2025-07-05 13:14 1.3K 
[   ]sl-13-antibacterial-..>2025-07-05 13:14 1.3K 
[   ]sl-14-peptide-gpcr-s..>2025-07-05 13:14 1.3K 
[   ]sl-15-ser-thr-kinase..>2025-07-05 13:14 1.3K 
[   ]sl-18-spiro-peptidom..>2025-07-05 13:14 1.3K 
[   ]sl-19-soft-electophi..>2025-07-05 13:14 1.3K 
[   ]sl-20-soft-electophi..>2025-07-05 13:14 1.3K 
[   ]sl-21-ido-inhibitors..>2025-07-05 13:14 1.3K 
[   ]sl-22-soft-electophi..>2025-07-05 13:14 1.3K 
[   ]sl-23-oncology-pheno..>2025-07-05 13:14 1.3K 
[   ]sl-24-stat-3.sdf.list 2025-07-05 13:14 1.3K 
[   ]sl-25-bh3-mimetics.s..>2025-07-05 13:14 1.3K 
[   ]sl-26-irak4-inhibito..>2025-07-05 13:14 1.3K 
[   ]sl-27-soft-electophi..>2025-07-05 13:14 1.3K 
[   ]sl-29-idh-inhibitors..>2025-07-05 13:14 1.3K 
[   ]sl-30-a-helix-mimeti..>2025-07-05 13:14 1.3K 
[   ]sl-31-ezh2-inhibitor..>2025-07-05 13:14 1.3K 
[   ]sl-32-bh3-mimetics-m..>2025-07-05 13:14 1.3K 
[   ]sl-33-pd1-pdl1-inhib..>2025-07-05 13:14 1.3K 
[   ]sl-34-beta-turn-mime..>2025-07-05 13:14 1.3K 
[   ]sl-35-mtt3-macro.sdf..>2025-07-05 13:14 1.3K 
[   ]sl-37-soft-electroph..>2025-07-05 13:14 1.3K 
[   ]sl-38-immuno-glycomi..>2025-07-05 13:14 1.3K 
[   ]sl-40-constrained-te..>2025-07-05 13:14 1.3K 
[   ]sl-41-voltage-gated-..>2025-07-05 13:14 1.3K 
[   ]sl-42-pkmt-inhibitor..>2025-07-05 13:14 1.3K 
[   ]sl-43-state-1t-inhib..>2025-07-05 13:14 1.3K 
[   ]sl-44-cns-pampa-bbb...>2025-07-05 13:14 1.3K 
[   ]sl-45-hdac-inhibitor..>2025-07-05 13:14 1.3K 
[   ]sl-47-bet-inhibitors..>2025-07-05 13:14 1.3K 
[   ]sl-48-apoe-activator..>2025-07-05 13:14 1.3K 
[   ]sl-49-smo-inhibitors..>2025-07-05 13:14 1.3K 
[   ]sl-54-menin-mll-inhi..>2025-07-05 13:14 1.3K 
[   ]sl-55-56-arabinose-g..>2025-07-05 13:14 1.3K 
[   ]sl-57-58-carbocyclic..>2025-07-05 13:15 1.3K 
[   ]sl-59-60-oxo-spiropy..>2025-07-05 13:15 1.3K 
[   ]sl-61-antimalarial-a..>2025-07-05 13:15 1.3K 
[   ]sl-62-microbial-b-gl..>2025-07-05 13:15 1.3K 
[   ]sl-63-preferred-rna-..>2025-07-05 13:15 1.3K 
[   ]sl-64-tmem16a-channe..>2025-07-05 13:15 1.3K 
[   ]sl-66-mir-21-inhibit..>2025-07-05 13:15 1.3K 
[   ]sl-67-mir-29-inhibit..>2025-07-05 13:15 1.3K 
[   ]sl-68-bacterial-ribo..>2025-07-05 13:15 1.3K 
[   ]sl-69-interferon-ifn..>2025-07-05 13:15 1.3K 
[   ]sl-70-hiv-tar-rna-sm..>2025-07-05 13:15 1.3K 
[   ]sl-71-taxol-mimetics..>2025-07-05 13:15 1.3K 
[   ]sl-73-dlk-map3k12-ki..>2025-07-05 13:15 1.3K 
[   ]sl-74-inhibitors-of-..>2025-07-05 13:15 1.3K 
[   ]sl-75-wnt-pathway-in..>2025-07-05 13:15 1.3K 
[   ]sl-76-oxyterpenoids-..>2025-07-05 13:15 1.3K 
[   ]sl-77-morpholines-fo..>2025-07-05 13:15 1.3K 
[   ]sl-78-sympathomimeti..>2025-07-05 13:15 1.3K 
[   ]sl-79-piperidines-fo..>2025-07-05 13:15 1.3K 
[   ]sl-80-analgesics.sdf..>2025-07-05 13:15 1.3K 
[   ]sl-81-trpa1-agonists..>2025-07-05 13:15 1.3K 
[   ]sl-82-p38-inhibitors..>2025-07-05 13:15 1.3K 
[   ]sl-84-trpc-3-6-7.sdf..>2025-07-05 13:15 1.3K 
[   ]sl-85-tubulin-inhibi..>2025-07-05 13:15 1.3K 
[   ]sl-86-kdm-inhibitors..>2025-07-05 13:15 1.3K 
[   ]sl-87-eif4a3-inhibit..>2025-07-05 13:15 1.3K 
[   ]sl-88-ffar-regulator..>2025-07-05 13:15 1.3K 
[   ]sl-89-drd2-inhibitor..>2025-07-05 13:15 1.3K 
[   ]sl-90-kor-agonist.sd..>2025-07-05 13:15 1.3K 
[   ]sl-91-faah-inhibitor..>2025-07-05 13:15 1.3K 
[   ]sl-92-nav17-antagoni..>2025-07-05 13:15 1.3K 
[   ]sl-93-gem-dime-heter..>2025-07-05 13:15 1.3K 
[   ]sl-94-4-anilinopiper..>2025-07-05 13:15 1.3K 
[   ]sl-95-3-anilinopiper..>2025-07-05 13:15 1.3K 
[   ]sl-96-phe-piperazine..>2025-07-05 13:15 1.3K 
[   ]sl-97-medium-sized-h..>2025-07-05 13:15 1.3K 
[   ]sl-99-pyrimidine-bas..>2025-07-05 13:15 1.3K